TDCs to Treat Drug-resistant Epilepsy
Other Forms of Epilepsy, Treatment Resistant
About this trial
This is an interventional treatment trial for Other Forms of Epilepsy, Treatment Resistant focused on measuring Drug-resistant epilepsy, tDCS
Eligibility Criteria
Inclusion Criteria: Age 18-90 montths Having tried at least two appropriate anti-epileptic drugs (AEDs) tested to tolerance or to blood levels at upper end of the target range of which at least 2 have been tolerated at normal dose. At least 2-3 seizure per month documented with EEG, not only clinically. In good health except epilepsy. Patients or his(her) familys could understand this method and sign the informed consent 7)Patients with good compliance and could complete postoperative follow-up. Exclusion Criteria: Results of MRI remind epilepsy caused by intracranial space-occupying lesions. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma,mental disease,pepticulcer,diabetes Type 1,bad health etc, and other surgical contraindication sleep-related breathing disorders
Sites / Locations
- Spanish Foundation for Neurometrics Development
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Refractory Epilepsy Group
Placebo Patients
50 patients with at least they have 3 crisis per week They Receive Cathodal tDCS We do EEG before and after intervention with 19 channels and the patient complete questionnarie: QUALITY OF LIFE IN EPILEPSY - QOLIE-31
50 patients with at least they have 3 crisis per week that receive SHAM They Not Receive Cathodal tDCS. We do EEG before and after intervention with 19 channels and the patient complete questionnarie: QUALITY OF LIFE IN EPILEPSY - QOLIE-31